2 news items
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
LGND
8 Apr 24
will depend on a number of factors including coverage and reimbursement levels from governmental authorities and health insurers as well as market
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMIâ„¢
LGND
3 Apr 24
including coverage and reimbursement levels from governmental authorities and health insurers as well as market acceptance by healthcare providers
- Prev
- 1
- Next